ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print December 19, 2007, 10.1183/09031936.00088907
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schelstraete, P.
Right arrow Articles by De Baets, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schelstraete, P.
Right arrow Articles by De Baets, F.
Eur Respir J 2008; 31:822-829
Copyright ©ERS Journals Ltd 2008

Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients

P. Schelstraete1, S. Van daele1, K. De Boeck2, M. Proesmans2, P. Lebecque3, J. Leclercq-Foucart4, A. Malfroot5, M. Vaneechoutte6 and F. De Baets1

1 Cystic Fibrosis Centres, Ghent University Hospital, Ghent, 2 University Hospital KULeuven, Leuven, 3 University Hospital UCL, Louvain-la-Neuve, 4 University Hospital ULG, Liège, 5 University Hospital UZBrussel, Brussels, 6 Dept of Clinical Chemistry, Bacteriology and Immunology, Ghent University Hospital, Ghent, Belgium.

CORRESPONDENCE: P. Schelstraete, Dept of Paediatrics, Cystic Fibrosis Centre 5K6, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium. Fax: 32 93323861. E-mail: petra.schelstraete{at}ugent.be

Keywords: Cystic fibrosis, environment, genotyping, Pseudomonas aeruginosa

Received: July 15, 2007
Accepted November 30, 2007

The source of acquisition of Pseudomonas aeruginosa in cystic fibrosis (CF) patients remains unknown. Patient-to-patient transmission has been well documented but the role of the environment as a source of initial infection is as yet unclear.

In the present study, the origin of the first P. aeruginosa isolate in CF patients was investigated by comparing the P. aeruginosa genotype(s) from newly infected patients with genotypes of P. aeruginosa isolates from the home environment and from other patients from the same CF centre.

A total of 50 newly infected patients were studied. P. aeruginosa could be cultured from 5.9% of the environmental samples, corresponding to 18 patients. For nine of these, the genotype of the environmental P. aeruginosa isolate was identical to the patient's isolate. In total, 72% of the environmental P. aeruginosa isolates were encountered in the bathroom. Patient-to-patient transmission within the CF centre could not be ruled out for three patients.

In summary, a low prevalence of Pseudomonas aeruginosa was found in the home environment of the newly infected cystic fibrosis patients. The bathroom should be targeted in any preventive cleaning procedures. An environmental source of the new infection could not be ruled out in nine patients.




This article has been cited by other articles:


Home page
Chronic Respiratory DiseaseHome page
T. Lee
Eradication of early Pseudomonas infection in cystic fibrosis
Chronic Respiratory Disease, May 1, 2009; 6(2): 99 - 107.
[Abstract] [PDF]


Home page
Eur Respir JHome page
J. Barben and J. Schmid
Dental units as infection sources of Pseudomonas aeruginosa
Eur. Respir. J., October 1, 2008; 32(4): 1122 - 1123.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the European Respiratory Society.